Subclinical atherosclerosis in young Thai adults with juvenile-onset systemic lupus erythematosus

被引:0
|
作者
Pattrakornkul, Nalinee [1 ]
Pruangprasert, Patamakom [1 ]
Chanthong, Prakul [1 ]
Chawanasuntorapoj, Ratana [2 ]
Pattaragarn, Anirut [1 ]
机构
[1] Mahidol Univ, Siriraj Hosp, Dept Pediat, Fac Med, Bangkok 10700, Thailand
[2] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Med, Bangkok 10700, Thailand
关键词
Atherosclerosis; carotid intima-media thickness; juvenile-onset systemic lupus erythematosus; subclinical atherosclerosis; systemic lupus erythematosus; INTIMA-MEDIA THICKNESS; CARDIOVASCULAR-DISEASE; RISK-FACTORS; CAROTID ATHEROSCLEROSIS; CYCLOSPORINE-A; BLOOD-PRESSURE; PROGRESSION; ALBUMINURIA; NEPHRITIS; UPDATE;
D O I
10.5372/1905-7415.1002.475
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Cardiovascular disease (CVD) is a leading cause of morbidity and mortality in adult patients with systemic lupus erythematosus (SLE). Increased risk of CVD and atherosclerosis has been demonstrated in children with SLE. However, evidence of atherosclerosis in adults with juvenile-onset SLE is limited and their additional CVD risk factors unclear. Objectives: To investigate the presence of subclinical atherosclerosis in young Thai adults with juvenile-onset SLE, and evaluate atherosclerotic risk factors. Methods: We recruited a cohort of patients aged 18-40 years who had been diagnosed SLE before the age of 18 years for this observational study. Patients with chronic kidney disease stage IV or V, alcoholism, chronic liver disease, or life threatening illness were excluded. Common carotid intima-media thickness (CCIMT) was measured. Clinical and laboratory parameters, treatment, and SLE-related factors, which could be risk factors for atherosclerosis and classic risk factors were obtained. Results: We enrolled 29 patients (24 female). Their mean age was 25.1 years and mean disease duration 11.3 years. The age of participants, persistent proteinuria and use of cyclosporin correlated with increased CCIMT by multivariable analysis (P = 0.02, 0.02, and 0.03, respectively). These patients had significantly abnormal CCIMT when compared with a healthy population (mean 690 (SD 150) mu m versus mean 447 (SD 76) mu m, respectively; P < 0.001). Conclusions: Subclinical atherosclerosis, identified by abnormal CCIMT, appears in young adults with juvenile-onset SLE. The CCIMT abnormality progresses with increasing age, and persistent proteinuria and use of cyclosporin appears to increase the risk for atherosclerosis.
引用
收藏
页码:139 / 146
页数:8
相关论文
共 50 条
  • [1] Study of early atherosclerosis in juvenile-onset systemic lupus erythematosus patients
    Emtethal A. Said Ahmed
    Sahar S. Ganeb
    Ahmed Y. El-shambaky
    Osama T. Galal
    Mai Y. Tohamy
    Egyptian Rheumatology and Rehabilitation, 2017, 44 (1) : 11 - 16
  • [2] DAMAGE IN JUVENILE-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS
    Reis, P. Costa
    Isgro, J.
    Nativ, S.
    Yildirim-Toruner, C.
    Starr, A.
    Imundo, L.
    Eichenfield, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 267 - 267
  • [3] Vasculitis in Juvenile-Onset Systemic Lupus Erythematosus
    Smith, Eve M. D.
    Lythgoe, Hanna
    Hedrich, Christian M.
    FRONTIERS IN PEDIATRICS, 2019, 7
  • [4] Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus: Data from the UK Juvenile-onset systemic lupus erythematosus cohort study
    Giani, Teresa
    Smith, Eve Md
    Al-Abadi, Eslam
    Armon, Kate
    Bailey, Kathryn
    Ciurtin, Coziana
    Davidson, Joyce
    Gardner-Medwin, Janet
    Haslam, Kirsty
    Hawley, Dan P.
    Leahy, Alice
    Leone, Valentina
    McErlane, Flora
    Mewar, Devesh
    Modgil, Gita
    Moots, Robert
    Pilkington, Clarissa
    Pregnolato, Francesca
    Ramanan, Athimalaipet, V
    Rangaraj, Satyapal
    Riley, Phil
    Sridhar, Arani
    Wilkinson, Nick
    Cimaz, Rolando
    Beresford, Michael W.
    Hedrich, Christian M.
    LUPUS, 2021, 30 (12) : 1955 - 1965
  • [5] Subclinical deterioration of left ventricular function in patients with juvenile-onset systemic lupus erythematosus
    Chung, H-T
    Huang, Y-L
    Yeh, K-W
    Huang, J-L
    LUPUS, 2015, 24 (03) : 263 - 272
  • [6] Cardiovascular Morbidity in Juvenile-onset Systemic Lupus Erythematosus
    Quinlan, Catherine
    Marks, Stephen
    Tullus, Kjell
    PEDIATRIC NEPHROLOGY, 2012, 27 (09) : 1731 - 1731
  • [7] Neuropsychiatric Involvement in Juvenile-Onset Systemic Lupus Erythematosus
    Khajezadeh, Mohammad-Amin
    Zamani, Gholamreza
    Moazzami, Bobak
    Nagahi, Zahra
    Mousavi-Torshizi, Mahdie
    Ziaee, Vahid
    NEUROLOGY RESEARCH INTERNATIONAL, 2018, 2018
  • [8] CARDIOVASCULAR RISK IN JUVENILE-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS
    Quinlan, C.
    Kari, J.
    Pilkington, C.
    Marks, S.
    Tullus, K.
    INTERNAL MEDICINE JOURNAL, 2014, 44 : 32 - 32
  • [9] Treatment Options for Juvenile-Onset Systemic Lupus Erythematosus
    Luis Carreño
    Francisco Javier López-Longo
    Carlos Manuel González
    Indalecio Monteagudo
    Pediatric Drugs, 2002, 4 (4) : 241 - 256
  • [10] Bone Health in Juvenile-Onset Systemic Lupus Erythematosus
    Chang, Caroline
    Pitukcheewanont, Pisit
    CURRENT RHEUMATOLOGY REVIEWS, 2012, 8 (03) : 199 - 208